跳至主要内容
临床试验/CTRI/2024/02/062475
CTRI/2024/02/062475尚未招募2 期

Evaluating the therapeutic effects of Safuf-e-Talmakhana in the management of Qillat-e-Haiwain-e-Manviya (Oligospermia): A randomised, open-label study with standard control - NI

Central Research Institute of Unani Medicine (CCRUM), New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Sperm count less than 20 million per ml.
  • Married patients between 21 to 50 years of age
  • Patients willing to sign written informed consent.

排除标准

  • 1) Diagnosed patients of Azoospermia and Aspermia.
  • 2) Patients having history of genetic defects like Klinefelter’s Syndrome.
  • 3) Patients having Hernia, Varicocele, Hypogonadism, Testicular Atrophy,
  • Undescended Testis excluded by clinical examination.
  • 4) Patients having Thyroid dysfunction.
  • 5) Patients with cardiac diseases and chronic renal failure.
  • 6) Patients having uncontrolled diabetes mellitus and Hypertension.
  • 7) Patients who fail to follow up.

研究者

发起方
Central Research Institute of Unani Medicine (CCRUM), New Delhi

相似试验